MoS(2)-based nanocomposites for cancer diagnosis and therapy.
MoS(2)-based nanocomposites for cancer diagnosis and therapy.
复制标题
DOI:
10.1016/j.bioactmat.2021.04.021
复制
发表时间:
2021-11
影响因子:
18.9
通讯作者:
Ai K
中科院分区:
文献类型:
--
作者:
Wang J;Sui L;Huang J;Miao L;Nie Y;Wang K;Yang Z;Huang Q;Gong X;Nan Y;Ai K
Molybdenum is a trace dietary element necessary for the survival of humans. Some molybdenum-bearing enzymes are involved in key metabolic activities in the human body (such as xanthine oxidase, aldehyde oxidase and sulfite oxidase). Many molybdenum-based compounds have been widely used in biomedical research. Especially, MoS2-nanomaterials have attracted more attention in cancer diagnosis and treatment recently because of their unique physical and chemical properties. MoS2 can adsorb various biomolecules and drug molecules via covalent or non-covalent interactions because it is easy to modify and possess a high specific surface area, improving its tumor targeting and colloidal stability, as well as accuracy and sensitivity for detecting specific biomarkers. At the same time, in the near-infrared (NIR) window, MoS2 has excellent optical absorption and prominent photothermal conversion efficiency, which can achieve NIR-based phototherapy and NIR-responsive controlled drug-release. Significantly, the modified MoS2-nanocomposite can specifically respond to the tumor microenvironment, leading to drug accumulation in the tumor site increased, reducing its side effects on non-cancerous tissues, and improved therapeutic effect. In this review, we introduced the latest developments of MoS2-nanocomposites in cancer diagnosis and therapy, mainly focusing on biosensors, bioimaging, chemotherapy, phototherapy, microwave hyperthermia, and combination therapy. Furthermore, we also discuss the current challenges and prospects of MoS2-nanocomposites in cancer treatment. MoS2 with a large specific surface area can combine a variety of molecules to form a multifunctional nano-platform. MoS2 with excellent optical absorption and photothermal conversion efficiency can be used in cancer therapy and bioimaging. MoS2-nanocomposite can specifically respond to the tumor microenvironment and reduce side effects on non-cancerous tissues.
登录
查看更多内容
影响因子:
6.2
作者:
Bode C;Zhao G;Steinhagen F;Kinjo T;Klinman DM
通讯作者:
Klinman DM
影响因子:
38.3
作者:
Chen, Peng;Pan, Dun;Shi, Yongyong
通讯作者:
Shi, Yongyong
影响因子:
8.8
作者:
通讯作者:
--
DOI:
10.1073/pnas.0813019106
发表时间:
2009-03-17
影响因子:
11.1
作者:
Bouchard, Louis-S.;Anwar, M. Sabieh;Chen, Fanqing Frank
通讯作者:
Chen, Fanqing Frank
影响因子:
10.6
作者:
Audigier, Chloe;Mansi, Tommaso;Comaniciu, Dorin
通讯作者:
Comaniciu, Dorin